Revlimid Capsule
Product Images NDC 59572-405
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Revlimid (NDC 59572-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Revlimid 02)
Figure (Revlimid 03)
Figure (Revlimid 04)
Figure (Revlimid 05)
Figure (Revlimid 06)
Figure (Revlimid 07)
Figure (Revlimid 07a)
2_5mg-28capsules (2 5mg 28capsules)
5mg-28capsules (5mg 28capsules)
10mg-28capsules (10mg 28capsules)
15mg-21capsules (15mg 21capsules)
20mg-21capsules (20mg 21capsules)
25mg-21capsules (25mg 21capsules)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.